Yüklüyor......
An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision
Axial spondyloarthritis (axSpA) is a group of debilitating, chronic, rheumatic conditions characterized by inflammation and new bone formation, mainly involving the spine and the sacroiliac joints. The lack of biomarkers in axSpA is well known. Despite significant treatment advances in recent years...
Kaydedildi:
| Yayımlandı: | Ther Adv Musculoskelet Dis |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7315656/ https://ncbi.nlm.nih.gov/pubmed/32636944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20934277 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|